Infrastructure development works worth Rs 52,000 cr underway in Hyderabad: Bhatti | Hyderabad News

Deputy Chief Minister Mallu Bhatti Vikramarka purchases travel passes from Transport Minister Ponnam Prabhakar after launching the unified common travel pass for Hyderabad Metro and TGSRTC city buses at Praja Bhavan in Hyderabad on Friday. Pic: Venkat Rao M Hyderabad: Infrastructure works worth Rs 52,000 crore are underway in Hyderabad to meet the city’s future…

Read More

State’s alcohol revenue dependence among highest, growth among slowest | Hyderabad News

Hyderabad: Telangana derives a larger share of its own-tax revenue from alcohol than several major states, even as growth in alcohol tax revenue has remained among the slowest, according to a Telangana government revenue brief.According to analysis by the industry sources, alcohol accounted for 31.8% of Telangana’s own-tax revenue in 2024-25, the highest among states…

Read More

Aurobindo arm Apitoria acquires A1 Biochem Labs LLC in $15.25M cash deal | Hyderabad News

Hyderabad: Aurobindo Pharma Friday said its subsidiary Apitoria Pharma Private Limited has completed the acquisition of US-based contract research and chemistry services company, A1 Biochem Labs LLC, for a cash consideration of $15.25 million (around Rs 147 crore).The acquisition follows Aurobindo’s earlier announcement that its wholly owned subsidiary Apitoria Pharma is acquiring the contract research…

Read More

Talking turkey: Feed additives help boost meat production, says study | Hyderabad News

Hyderabad: A blend of thymol, a compound found in thyme and oregano, and formic acid helped turkeys gain more weight while using feed more efficiently, an Indian study involving a Hyderabad researcher has found. The findings suggest a possible alternative to antibiotics used to promote growth in commercial turkey farming.Published in Scientific Reports on Sept…

Read More

CCMB study maps multi-pronged route to tackle ‘cold’ solid tumours | Hyderabad News

Hyderabad: Breaking down a tumour’s physical and immune defences before deploying engineered immune cells could improve treatment of hard-to-penetrate solid cancers such as pancreatic ductal adenocarcinoma and glioblastoma, according to a review led by researchers at the CSIR-Centre for Cellular and Molecular Biology (CCMB).The paper, ‘Integrated systems from small molecule modulators to next generation cell…

Read More